Microbubbles May Boost Response to Transarterial Radioembolization for the Most Common Form of Liver Cancer
In a first-of-its-kind clinical trial, researchers at Thomas Jefferson University demonstrated the safety of combining ultrasound-triggered microbubble destruction and transarterial radioembolization (TARE) to treat patients with hepatocellular carcinoma — and found that combining the therapies was nearly twice as effective as TARE alone.
A recent systematic review found that for patients who underwent pelvic organ prolapse (POP) surgery, pain with sex decreased and overall sexual function improved or was unchanged. The results may inform how surgeons discuss POP surgery with patients.
Three new studies show protein biomarkers can identify Alzheimer’s Disease years before people have symptoms.
Researchers have discovered nontraditional techniques to identify Parkinson’s disease as early as possible, offering hope for patients seeking answers during the early stages of this difficult-to-diagnose neurological condition.
A 2017 study in The BMJ found that older doctors had higher patient mortality rates. And a 2010 JAMA survey found that over a third of physicians didn’t report colleagues they knew to be incompetent or impaired.
Researchers explore a new use for prazosin.
A groundbreaking study reveals an ultra-rare genomic variant often presents in patients with schizophrenia, providing more information on effective treatment options for a complicated disorder.
A new study may help men make more informed decisions about prostate cancer treatment.
A new study could lead to better tailoring of treatments to individual patients.
A new study finds that decreases in two osteoporosis risk factors — smoking and heavy alcohol use — help account for a steady drop in hip fracture rates in the U.S. over 40 years.
- 1 of 13
- next ›